Hemangio Journal

This study evaluates the safety and efficacy of eBAT in treating dogs with hemangiosarcoma, showing promising results with mild side effects and potential to prolong survival.

This study explores how resveratrol supplementation may reduce chemotherapy-induced cardiac toxicity in dogs while enhancing anti-tumor effects in hemangiosarcoma.

The group that received full dendritic cell therapy had a median survival of 256 days, with a 29% one-year survival rate.

Study shows low prevalence of occult cancer in older dogs, with physical exams and cytology being key diagnostic methods.

Accurately counting mitotic figures (MFs) is key to tumor grading, but pathologists often struggle with consistency. New advances in digital pathology and deep learning could revolutionize MF detection.

Clopidogrel was evaluated for its potential to reduce hypercoagulability and thrombocytosis in dogs post-splenectomy.

This study examines CT features of pulmonary metastases in dogs with hemangiosarcoma, including small nodules, halo signs, and feeding vessels, highlighting the role of whole-body CT in staging HSA.

Insights from a risk assessment and early detection test of naturally occurring cancers in companion dogs

A Breakdown of Where Science Stands in Fighting The Elusive Disease

Heather Gardner’s work seeks to change the landscape of cancer detection and personalized treatments in dogs.

The CCA webinar highlighted latest updates: promising treatments, clinical research insights, and World Veterinarian Cancer Congress

A new retrospective study dives into both blood vessel tumors, seeking predictive markers for easier diagnosis.